Table 3. Results of brucellosis therapy in large patient series.
Author (year) [ref] | country | Years of study | N° cases | Therapeutic regimens | relapses | Failures | mortality | Hospital admission |
Barroso Garcia P (2002) [56] | Spain | 1972–1998 | 1595 | TETR+STP ; TETR+STP+ Sulphonamide ; DX+STP ; STP+Sulphonamide+DX ; TETR | NR | NR | NR | No |
Andropoulos (2007) [59] | Greece | 1990–2003 | 144 | DX+STP (>14 años); RF+TMP/SMX (niños) | 4 (3%) | NR | 0 | Yes |
Bosilkovski (2007) [57] | Macedonia | 1998–2004 | 418 | DX+RF+TMP/SMX ; DX+RF ; DX+RF+G | 16.2% | 10.4% | 1 | Yes (until improvement) |
Aygen (2002) [55] | Turkey | 1989–1998 | 480 | DX+RF; DX+STP; TETR+STP; CPX | 26 (5.4%) | 0 | 3 | NR |
Memish (2000) [58] | Saudi Arabia | 1983–1995 | 160 | TETR+STP; DX+RF; TETR+STP+ RF; RF+TMP/SMX; RF+STP+TMP/SMX | 7 | NR | 0 | Yes |
Buzgan (2010) [65] | Turkey | 1998–2007 | 1028 | DX+RF (most used); DX+STP; DX+RF+STP; DX+CPX; RF+TMP/SMX; RF+CPX | 4.7% | NR | NR | Yes (2–3 weeks) |
Al Shaalan (2002) [60] | Saudi Arabia | 1984–1995 | 115 (children) | RF+TMP/SMX+STP; STP+TMP/SMX; RF+TMP/SMX; STP+TETR+TMP/SMXl; RF+DX+STP | 8 | NR | 1 | Yes |
Savas l (2007) [61] | Turkey | 2000–2002 | 140 | DX+RF; DX+STP; RF+CPX; DX+RF+STP; RF+TMP/SMX | 5 | NR | 0 | Yes(37 patients) |
Demirturk (2008) [62] | Turkey | 2002–2006 | 99 | DX+RF; DX+RF+CPX | 0 (of 30 cases with follow up) | 0 | 1 | Yes |
TETR = tetracycline, STP = streptomycin, DX = doxycycline, RF = rifampicin, TMP/SMX = cotrimoxazole, G = gentamicin, CPX = ciprofloxacin.